I n s p I r e d

C A N C E R

C a r e

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r

s I d n e y M . O M a n C a n C e r T r e a T M e n T C e n T e r

2 0 1 4 a n n u a l r e p o r t

Chesapeake Regional

Medical Center’s

Sidney M. Oman Cancer

Treatment Center

specializes in providing the

full range of care

needed by cancer patients.

Staffed by dedicated

professionals

who see every patient

as a whole person, we specialize

in bringing about the

best possible outcomes.

O u r M I s s I O n

The Sidney M. Oman Cancer Treatment

Center has provided service to the Hampton

Roads community for nineteen years.

Because the needs of our community are

constantly changing, we consistently review

our performance and strive to deliver world

class service. We have always focused our

compassion and care on the patients and

their families. Our team delivers a

comprehensive program including

nutrition counseling, psycho-social

distress management, American Cancer

Society/ Chesapeake Regional Medical

Center patient resource navigation,

survivorship care plans, as well as

oncology-certified staffing throughout the

facility. The Cancer Treatment Center

consists of the Radiation Oncology

Program, an Outpatient Infusion Unit and

the Cancer Registry.

Our Radiation Oncology Program offers

external beam radiation, low-dose rate

prostate seed implantation, high-dose rate

partial breast treatment, and high-dose rate

Our

InspIratIon

Comes

From

the

Patients For

Whom We

Provide

Compassionate,

Focused,

Cancer

Care.

c a n c e r p r o g r a m a d m i n i s t r a t o r

a m e s s a g e f r o m b a r b a r a b e l l i d o , r t t ,

cylinder treatment. Our radiation

oncologist prescribed 338 patients to a

new course of treatment in 2014. The

radiation therapist performed 8,145

external beam radiation treatments and

the Brachytherapy Program recorded 14

prostate seed implants, 17 partial breast

treatments and four cylinder treatments.

The Outpatient Infusion Unit performs

procedures ranging from injections to

blood transfusions and chemotherapy. In

2014 our registered nurses performed

approximately 5,200 procedures. On

average, they saw 13 patients daily.

Our team consists of an operations

manager, radiation oncologists, medical

physicists, a medical dosimetrist, radiation

therapists, oncology nurses and patient

service associates, as well as a cancer

coordinator, abstractor and follow up clerk

for the registry. Our extraordinary team is

committed to delivering superior

outcomes for our patients.

Barbara Bellido, RTT

In 2014, Chesapeake Regional Medical

Center supported patient and community

outreach in a number of ways.

• CRMC participated throughout the year

with several sponsored walks including:

National Walking Day, Dismal Swamp

Stomp, Kick Cancer in the Butt:

Greenbrier 5k Walk for Colon Cancer,

Relay for Life and the Komen Race for

the Cure.

• CRMC’s Totally Pink for Life, an

exercise program designed to help

women with breast cancer, continued to

be offered throughout the year, including

several exercise sessions and stress

management sessions.

• Supermarket tours were conducted via

a registered dietician to educate community

members on good nutrition and label

reading.

• Physical therapy and lymphedema

services were provided by certified

lymphedema specialists.

• Skin cancer screenings were offered

on site and at local businesses:

-Derma Scan Screening and Skin

Cancer Lecture at Dollar Tree- 55

participants

-Skin Cancer Screening at Sidney

M. Oman Cancer Treatment Center-

95 screened/58 normal/37 referred/six

basal or squamous cell/one melanoma.

• The Bra-Ha-Ha® kickoff was held

Friday, Sept. 26, 2014. Decorated bras

were displayed at the Greenbrier mall

from Sept. 29- Oct. 12. This event is a

seriously uplifting way to raise awareness

about breast cancer. Funds raised from

this event provide mammograms and

related breast care services to underserved

women in southeastern Virginia and

northeastern North Carolina.

• The Great American Smoke Out was held

Thursday, Nov. 20. The American Cancer

Society designates the third Thursday of

November to encourage smokers to go the

distance and give up smoking. An

informational display was set up in the

hospital as well as in the Lifestyle Center

to educate employees and the public

about CRMC smoking cessation

resources.

• Chesapeake Regional offers internal

health promotion opportunities to its

employees that include: smoking

cessation classes, the HealthyMe program,

health-related seminars throughout the

year and staff education lectures. CRMC

also offers health promotion incentives as

a show of our dedication to the health and

wellness of our employees

At Chesapeake

Regional,

Our Goal Is To

Offer The

Community

a Tailored

Cancer Care

Program.

Our Effort To

Provide

Comprehensive

Care and

Prevention

Extends Into The

Community.

o u t r e a c h c a n c e r c a r e p r o g r a m s

o u r p a t i e n t a n d c o m m u n i t y o u t r e a c h

The Cancer Committee consists of primary and specialty care physicians and representatives from hospital departments

involved in the care of cancer patients. This multidisciplinary committee meets quarterly to review and evaluate the

quality of care for cancer patients at Chesapeake Regional Healthcare. They oversee the overall direction of the program

and make recommendations for improvements.

Chairman Valiant Tan, M.DCancer Liaison Physician Bruce Waldholtz, M.D.Cancer Conference Coordinator William Clark, M.D.Medical Oncology William Clark, M.D.Radiation Oncology Mathew Sinesi, M.D./ Christopher Sinesi, M.D.Diagnostic Radiology Michael Petruschak, M.D.Quality Improvement Coordinator Dan Albrecht, D.O.Pathology Dan Albrecht, D.O.Cancer Program Administrator Barbara Bellido, RTTOncology Nurse Aurora Cruz, R.N.Palliative Care Gabriella Miller, M.D.Certified Tumor Registrar Athena Bullard, CTRCancer Registry Quality Coordinator Athena Bullard, CTRQuality Performance Representative Jan Young, R.N.Executive Office Eric DaltonRehabilitation Services Melinda Shuler, MPT, CMLDT Pharmacy Shelly Collins/Doug Crowe, RPhPatient Resource Navigator Ellie DuarteBreast Care Center Lou Verdes, R.N.Dietary Services Charlene CurtisPastoral Care Reverend Marie Pogorelec, CPSPHospice/Palliative Care Donna Marchant-Roof, MSW, LCSW, ACHPSWAmerican Cancer Society Jan BennettCancer Registry Follow up Diane BatchelderHIM Elizabeth Leff, RHIA

REGISTRY PARTNERS Brandi King, CTR/ Laura Leon, CTR

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r

2 0 1 4 c a n c e r c o m m i t t e e m e m b e r s

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r

c a n c e r c o n f e r e n c e s

Jan Feb March April May June July August Sept Oct Nov Dec TotalBreast 9 10 10 8 12 5 14 11 8 13 4 8 112Colon 3 1 2 0 1 2 3 0 3 0 1 0 16Lung 2 2 1 1 3 1 1 1 0 2 2 2 18Prostate 0 0 0 0 0 0 0 0 0 1 1 0 2All Other Sites 3 1 5 2 5 5 4 2 1 5 4 2 39Total 188

020406080

100120140160180200

Num

ber o

f Cas

es

2014 CASES BY SITE PRESENTED AT CANCER CONFERENCE

In Fiscal Year 2014, 188 cases were

presented at 49 Cancer Conferences,

respectively. All cancer sites are discussed

during these conferences. However, every

other week, breast cases are presented, as

called for by the breast management pathway.

During this time, CRMC also hosted four

guest speakers to present cancer-focused

presentations to staff, outlining the most

up-to-date cancer treatments and trends.

This topic area is of educational value to both

the medical and ancillary staff.

All general and breast conference cases

should be directed to the Cancer Registry

at (757) 312-4144.

Dr. William Clark

moderates the

multidisciplinary

discussion at each

conference.

2 0 1 4 c a s e s b y c a s e p r e s e n t e d

a t c a n c e r c o n f e r e n c e

Cancer Conferences at Chesapeake Regional

Medical Center are held weekly on Thursday

mornings from 7 to 8 a.m. CRMC endeavors

to provide excellent personalized care;

therefore, cases are presented at each

conference in front of a multidisciplinary team

of surgeons, medical and radiation oncologists,

pathologists, diagnostic radiologists and

medical students. Representatives from social

services, the Cancer Registry, nursing and

radiation technicians are also in attendance.

A review of the cancer case and overview of

nationally recognized treatment guidelines are

discussed to ensure the best care for

each patient.

CANCER REGISTRY DATA - 2014

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r - 2 0 1 4 d a t a

d i a g n o s i s b y g e n d e r - n c i d i s t r i b u t i o n *

Total 1 2 34

5 6 7 8 9

101112131415161718192021222324252627282930313233343536373839404142434445

Diagnosis by Gender - NCI Distribution*

Chesapeake Regional Medical Center- 2014 Data Disease Site Males Females

Lip Oral Cavity Pharynx 10 (5.32 %) 5 (1.75 %) 15 (3.16 %)Esophagus 3 (1.60 %) 2 (0.70 %) 5 (1.05 %)Stomach 2 (1.06 %) 1 (0.35 %) 3 (0.63 %)Small Intestine 1 (0.53 %) 2 (0.70 %) 3 (0.63 %)Colon 8 (4.26 %) 16 (5.59 %) 24 (5.06 %)Rectum 12 (6.38 %) 8 (2.80 %) 20 (4.22 %)Anus 1 (0.53 %) 4 (1.40 %) 5 (1.05 %)Liver 2 (1.06 %) 4 (1.40 %) 6 (1.27 %)Pancreas 7 (3.72 %) 5 (1.75 %) 12 (2.53 %)Other Digestive Organ 1 (0.53 %) 1 (0.35 %) 2 (0.42 %)Larynx 7 (3.72 %) 3 (1.05 %) 10 (2.11 %)Lung 31 (16.49 %) 32 (11.19 %) 63 (13.29 %)Other Respiratory 2 (1.06 %) 0 (0.00 %) 2 (0.42 %)Bones and Joints 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Soft Tissue 2 (1.06 %) 3 (1.05 %) 5 (1.05 %)Melanoma skin 1 (0.53 %) 0 (0.00 %) 1 (0.21 %)Kaposis sarcoma 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Mycosis Fungoides 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Other Skin 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Breast Female 0 (0.00 %) 118 (41.26 %) 118 (24.89 %)Breast Male 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Cervix 0 (0.00 %) 6 (2.10 %) 6 (1.27 %)Corpus Uteri 0 (0.00 %) 33 (11.54 %) 33 (6.96 %)Ovary 0 (0.00 %) 5 (1.75 %) 5 (1.05 %)Other Female Genital 0 (0.00 %) 5 (1.75 %) 5 (1.05 %)Prostate 50 (26.60 %) 0 (0.00 %) 50 (10.55 %)Other Male Genital 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Urinary Bladder 24 (12.77 %) 13 (4.55 %) 37 (7.81 %)Kidney 7 (3.72 %) 4 (1.40 %) 11 (2.32 %)Other Urinary 1 (0.53 %) 1 (0.35 %) 2 (0.42 %)Eye and Orbit 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Brain & Nervous System 5 (2.66 %) 0 (0.00 %) 5 (1.05 %)Thyroid 2 (1.06 %) 1 (0.35 %) 3 (0.63 %)Other Endocrine System 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Non-Hodgkins Lymphoma 2 (1.06 %) 3 (1.05 %) 5 (1.05 %)Hodgkins Lymphoma 1 (0.53 %) 1 (0.35 %) 2 (0.42 %)Multiple Myeloma 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Lymphoid Leukemia 1 (0.53 %) 1 (0.35 %) 2 (0.42 %)Myeloid and Monocytic Leukemia 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)Leukemia other 0 (0.00 %) 0 (0.00 %) 0 (0.00 %)

1 (0.21 %)

Other Hematopoietic 0 (0.00 %) 1 (0.35 %) 1 (0.21 %)Unknown Sites 2 (1.06 %) 6 (2.10 %) 8 (1.69 %)

188 (100.00%) 286 (100.00%) 474 (100.00%)

Ill-Defined Sites 1 (0.53 %) 0 (0.00 %) 1 (0.21 %)Other 1 (0.53 %) 0 (0.00 %)Benign Brain and CNS 1 (0.53 %) 2 (0.70 %) 3 (0.63 %)TOTALS

Diagnosis by Gender - NCI Summary 3 Distribution - Business Rules Percentages Are:

This report provides total counts of diagnoses for each gender grouped according to standards defined in the National Cancer Institute document Formatting for Standard Cancer Center Summaries*, Interim Revision, June 2006, updated 2011. Corrections have been made for certain obvious typographical errors in this document, specifically for skin malignancies (reversal of contents of ICD-O-3 cells for Melanoma and Other Skin) , Brain (addition of sites C70.2-C70.8), and "Other Female Genital" (inclusion of vaginal malignancies). In addition, the NCI

Classification has been augmented with the addition of a category for benign and borderline brain tumors.

A secondary Class of Case filter has been added to the run-time dialog for your convenience. You can also define any Class of Case combination with the Gather or Filter instructions and just select "All Classes" when running this report.

The following data errors or omissions will prevent a case from being considered in this report: (a) Missing or invalid Class of Case , (b) missing or invalid Site Code, and (c) missing or invalid Histology Code

(d) Sex not specifically stated as (1) Male or (2) Female. A list of these excluded cases can be generated using the accompanying QA report.

In keeping with the NCI guidelines the report also excludes the following ("NCI Exclusions") unless otherwise requested: (a) carcinoma in-situ of the cervix,

(b) intra-epithelial neoplasia, (c) basal cell skin cancers., and

(d) benign and borderline tumors other than CNS

Suspense cases that otherwise fit the criteria will be included.

Cases that are shared by more than one facility are counted just once.

This report has been sorted by NCI standard.

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r - 2 0 1 4 d a t a d i a g n o s i s b y g e n d e r - n c i s u m m a r y

Diagnosis by Gender - NCI Summary 3 Distribution - Business Rules Percentages Are:

This report provides total counts of diagnoses for each gender grouped according to standards defined in

the National Cancer Institute document Formatting for Standard Cancer Center Summaries*, Interim

Revision, June 2006, updated 2011. Corrections have been made for certain obvious typographical errors in

this document, specifically for skin malignancies (reversal of contents of ICD-O-3 cells for Melanoma and

Other Skin) , Brain (addition of sites C70.2-C70.8), and “Other Female Genital” (inclusion of vaginal

malignancies). In addition, the NCI Classification has been augmented with the addition of a category

for benign and borderline brain tumors.

A secondary Class of Case filter has been added to the run-time dialog for your convenience. You can also

define any Class of Case combination with the Gather or Filter instructions and just select “All Classes”

when running this report.

The following data errors or omissions will prevent a case from being considered in this report:

(a) Missing or invalid Class of Case,

(b) missing or invalid Site Code, and

(c) missing or invalid Histology Code

(d) Sex not specifically stated as (1) Male or (2) Female

A list of these excluded cases can be generated using the accompanying QA report.

In keeping with the NCI guidelines the report also excludes the following (“NCI Exclusions”)

unless otherwise requested:

(a) carcinoma in-situ of the cervix,

(b) intra-epithelial neoplasia,

(c) basal cell skin cancers., and

(d) benign and borderline tumors other than CNS

Suspense cases that otherwise fit the criteria will be included.Cases that are shared by more than one

facility are counted just once.

This report has been sorted by NCI standard.

c a n c e r r e g i s t r y - 2 0 1 4 d a t a

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r t o p 1 0 s i t e s

139

78

50

37 33 3121 19 17 13

0

20

40

60

80

100

120

140

160

Breast Lung Prostate UrinaryBladder

Corpus Uteri Colon Rectum Lip OralCavity

Pharynx

Pancreas Larynx

Chesapeake Regional Medical Center Top 10 Sites

Code Count

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r - 2 0 1 4 d a t a

a n a l y t i c c a s e s b y a g e

Age # of Cases10-19 020-29 830-39 1040-49 5150-59 12360-69 15970-79 13580-89 4490+ 11

541

0

20

40

60

80

100

120

140

160

180

10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90+

Number of cases

ANALYTIC CASES BY AGE

Age by Decade

Age # of Cases10-19 020-29 830-39 1040-49 5150-59 12360-69 15970-79 13580-89 4490+ 11

541

0

20

40

60

80

100

120

140

160

180

10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90+

Number of cases

ANALYTIC CASES BY AGE

Age by Decade

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r - 2 0 1 4 d a t a

a n a l y t i c c a s e s b y c i t y

332

71

27 18 16 13 9 4 0

50

100

150

200

250

300

350

Chesapeake Va Beach Norfolk Moyock Portsmouth ElizabethCity

Suffolk Currituck

ANALYTIC CASES DISTRIBUTION BY CITY Code count

c h e s a p e a k e r e g i o n a l m e d i c a l c e n t e r - 2 0 1 4 d a t a

t o p a j c c 2 4 s i t e s

Top AJCC 24 SitesDiagnostic Site Alive Dead Ana NonA Male Female 0 I II III IV NA UNK Total % Total

1 Breast Female 115 3 118 0 0 118 17 48 38 9 3 0 3 118 24.89 2 Lung 37 26 63 0 31 32 0 5 4 15 32 1 6 63 13.29 3 Prostate 48 2 50 0 50 0 0 5 41 1 3 0 0 50 10.55 4 Urinary Bladder 34 3 37 0 24 13 27 0 5 1 3 0 1 37 7.81 5 Corpus Uteri 33 0 33 0 0 33 0 25 1 1 1 0 5 33 6.96 6 Colon 18 6 24 0 8 16 0 5 9 4 4 0 2 24 5.06 7 Rectum 18 2 20 0 12 8 1 4 4 8 0 0 3 20 4.22 8 Lip Oral Cavity Pharynx 14 1 15 0 10 5 0 4 4 4 2 0 1 15 3.16 9 Pancreas 6 6 12 0 7 5 0 2 1 2 4 0 3 12 2.53 10 Kidney 10 1 11 0 7 4 0 4 3 1 2 0 1 11 2.32 11 Larynx 8 2 10 0 7 3 1 5 0 0 2 0 2 10 2.11 12 Unknown Sites 5 3 8 0 2 6 0 0 0 0 0 8 0 8 1.69 13 Liver 3 3 6 0 2 4 0 1 1 0 1 2 1 6 1.27 14 Cervix 6 0 6 0 0 6 0 3 0 1 2 0 0 6 1.27 15 Ovary 5 0 5 0 0 5 0 0 2 1 1 0 1 5 1.05 18 Anus 5 0 5 0 1 4 2 1 2 0 0 0 0 5 1.05 19 Esophagus 4 1 5 0 3 2 0 1 1 1 1 0 1 5 1.05 20 Soft Tissue 5 0 5 0 2 3 0 1 0 2 2 0 0 5 1.05 21 Stomach 1 2 3 0 2 1 0 0 1 1 1 0 0 3 0.63 22 Small Intestine 3 0 3 0 1 2 0 3 0 0 0 0 0 3 0.63 23 Thyroid 3 0 3 0 2 1 0 1 1 1 0 0 0 3 0.63 24 Benign Brain and CNS 3 0 3 0 1 2 0 0 0 0 0 3 0 3 0.63